
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Centene Corporation navigates a dynamic healthcare landscape with Q4 earnings beat, strategic appointments, and community investments, impacting its market position.
Centene (CNC) Q4 earnings beat expectations, driven by membership growth. Rising medical costs and Medicaid changes pose challenges, but community investments offer long-term value.
Centene (CNC) Q4 2024 earnings beat expectations, driven by membership growth. Rising medical costs and policy changes present challenges. Community investment and ICHRA are key strategies.
Centene's Q4 2024 earnings beat estimates, but rising medical costs and Medicaid challenges loom. Strategic adjustments and community investments are key.
Centene (CNC) Q4 earnings beat estimates, driven by membership growth and strategic ACA marketplace expansion. Key takeaways and strategic implications inside.
Centene Corporation's Q4 2024 results beat estimates with robust commercial growth offsetting Medicaid declines, paving a strong path for 2025.
Centene Corporation (CNC) reports strong Q4 2024 earnings, driven by commercial plan growth and strategic community investments, signaling robust market positioning.
Centene Corporation's Q4 2024 earnings beat estimates, driven by membership growth and strength in commercial health insurance plans, setting a positive tone for 2025.
Centene Corporation’s Q4 2024 earnings exceeded expectations with robust membership growth and a promising 2025 outlook.